Periocular Basal Cell Carcinoma - Clinical Perspectives

Overview

Journal Oncol Rev

Specialty Oncology

Date 2020 May 13

PMID 32395200

Citations 11

Authors

Alena Furdova

Karolina Kapitanova

Alexandra Kollarova

Juraj Sekac

Affiliations

Soon will be listed here.

Abstract

Basal cell carcinoma (BCC) as a non-melanoma skin cancer type is the most common malignant tumor throughout the world. The incidence is higher in age over 60. The intense of exposure to ultraviolet radiation is one of the known risk factors. Over 50% of BCC of the periocular region initially occur on the lower lid and inner angle. Literature review of treatment options for basal cell carcinoma, which consist of surgery, or combined techniques plus vismodegib, radiotherapy and imiquimod. The first consideration for treatment of periocular BCC is radical surgical excision using Mohs micrographic technique. Functional and esthetic outcome in patients are important after clear excisions and reconstruction should be carefully considered. Radical exenteration is considered in the case of orbital invasion of high-risk aggressive BCC.

Citing Articles

Palliative Radiotherapy to Preserve Eyesight in a Recurrent, Difficult-to-Treat Basal Cell Carcinoma.

Copilau A, Balaceanu-Gurau B, Anghel A, Tudose I, Mihai M Cureus. 2025; 17(1):e77743.

PMID: 39981494 PMC: 11839891. DOI: 10.7759/cureus.77743.

Nodular basal cell carcinoma masquerading as traumatic laceration.

Ahmed S, Sahota D, Ghosh Y BMJ Case Rep. 2025; 15(9).

PMID: 39901396 PMC: 9454036. DOI: 10.1136/bcr-2021-246620.

Clinical Outcomes and Prognostic Factors in Eyelid Malignancy: A 17-Year Retrospective Analysis of Surgical Management and Reconstruction Techniques.

Al Harthi A, Alharthi A, Park J, Yang S Korean J Ophthalmol. 2024; 39(1):14-22.

PMID: 39434573 PMC: 11856049. DOI: 10.3341/kjo.2024.0003.

Orbital Lesions: A bird's eye view of series of 2068 cases in 27 years in a tertiary care hospital in Pakistan.

Khan A, Latif S, Khan M, Ahmad I Pak J Med Sci. 2024; 40(8):1625-1631.

PMID: 39281227 PMC: 11395349. DOI: 10.12669/pjms.40.8.9843.

Results of Mohs' Micrographic Surgery of Periocular Basal Cell Carcinoma: The Swedish Experience.

Erripi K, Paussen D, Svedberg K Acta Derm Venereol. 2024; 104:15765.

PMID: 38566404 PMC: 11000588. DOI: 10.2340/actadv.v104.15765.

References

Ding S, Sagiv O, Guo Y, Kandl T, Thakar S, Esmaeli B . Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual. Ophthalmic Plast Reconstr Surg. 2018; 35(1):38-41. DOI: 10.1097/IOP.0000000000001133. View

Moreno-Arias G, Carrasco M, Camps-Fresneda A . Second intention healing after Mohs micrographic surgery. J Eur Acad Dermatol Venereol. 2000; 14(3):159-65. DOI: 10.1046/j.1468-3083.2000.00046.x. View

Papastefanou V, Rene C . Secondary Resistance to Vismodegib After Initial Successful Treatment of Extensive Recurrent Periocular Basal Cell Carcinoma with Orbital Invasion. Ophthalmic Plast Reconstr Surg. 2015; 33(3S Suppl 1):S68-S70. DOI: 10.1097/IOP.0000000000000565. View

Goldenberg G, Karagiannis T, Palmer J, Lotya J, ONeill C, Kisa R . Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study. J Am Acad Dermatol. 2016; 75(5):957-966.e2. DOI: 10.1016/j.jaad.2016.06.020. View

Garcia-Martin E, Idoipe M, Gil L, Pueyo V, Alfaro J, Pablo L . Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas. J Ocul Pharmacol Ther. 2010; 26(4):373-9. DOI: 10.1089/jop.2010.0030. View

Karagas M, Stukel T, Greenberg E, Baron J, Mott L, Stern R . Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA. 1992; 267(24):3305-10. View

Cinotti E, Perrot J, Campolmi N, Labeille B, Espinasse M, Grivet D . The role of in vivo confocal microscopy in the diagnosis of eyelid margin tumors: 47 cases. J Am Acad Dermatol. 2014; 71(5):912-918.e2. DOI: 10.1016/j.jaad.2014.05.060. View

Koyfman S, Cooper J, Beitler J, Busse P, Jones C, McDonald M . ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Head Neck. 2016; 38(2):175-82. DOI: 10.1002/hed.24171. View

Yu S, Zhao Y, Zhao H, Lin J, Tang X . A retrospective study of 2228 cases with eyelid tumors. Int J Ophthalmol. 2018; 11(11):1835-1841. PMC: 6232338. DOI: 10.18240/ijo.2018.11.16. View

10.

Gill H, Moscato E, Chang A, Soon S, Silkiss R . Vismodegib for periocular and orbital basal cell carcinoma. JAMA Ophthalmol. 2013; 131(12):1591-4. DOI: 10.1001/jamaophthalmol.2013.5018. View

11.

Sun M, Wu A, Huilgol S, Selva D . Accuracy of Biopsy in Subtyping Periocular Basal Cell Carcinoma. Ophthalmic Plast Reconstr Surg. 2015; 31(6):449-51. DOI: 10.1097/IOP.0000000000000372. View

12.

Yin V, Pfeiffer M, Esmaeli B . Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthalmic Plast Reconstr Surg. 2013; 29(2):87-92. PMC: 3878052. DOI: 10.1097/IOP.0b013e3182831bf3. View

13.

Ben Simon G, Schwarcz R, Douglas R, Fiaschetti D, McCann J, Goldberg R . Orbital exenteration: one size does not fit all. Am J Ophthalmol. 2005; 139(1):11-7. DOI: 10.1016/j.ajo.2004.07.041. View

14.

Marcil I, Stern R . Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000; 136(12):1524-30. DOI: 10.1001/archderm.136.12.1524. View

15.

Lear J, Smith A, Strange R, Fryer A . Patients with truncal basal cell carcinoma represent a high-risk group. Arch Dermatol. 1998; 134(3):373. DOI: 10.1001/archderm.134.3.373. View

16.

Garcia-Martin E, Gil-Arribas L, Idoipe M, Alfaro J, Pueyo V, Pablo L . Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol. 2011; 95(10):1393-6. DOI: 10.1136/bjo.2010.193078. View

17.

Conway R, Themel S, Holbach L . Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years. Br J Ophthalmol. 2004; 88(2):236-8. PMC: 1771977. DOI: 10.1136/bjo.2003.025056. View

18.

van Iersel C, van de Velden H, Kusters C, Spauwen P, Blokx W, Kiemeney L . Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol. 2005; 153(5):1078-80. DOI: 10.1111/j.1365-2133.2005.06911.x. View

19.

Furdova A, Lukacko P . Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit. J Craniofac Surg. 2016; 28(1):e84-e87. PMC: 5266411. DOI: 10.1097/SCS.0000000000003242. View

20.

Malhotra R, Huilgol S, Huynh N, Selva D . The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology. 2004; 111(4):631-6. DOI: 10.1016/j.ophtha.2003.11.004. View